These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20522093)

  • 1. The treatment of cognitive impairment associated with Parkinson's disease.
    Burn DJ
    Brain Pathol; 2010 May; 20(3):672-8. PubMed ID: 20522093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cognitive Training in Parkinson's Disease - A New Therapy Option?].
    Kalbe E; Folkerts AK
    Fortschr Neurol Psychiatr; 2016 Jul; 84 Suppl 1():S24-35. PubMed ID: 27192506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?
    Vale S
    Exp Biol Med (Maywood); 2008 Aug; 233(8):941-51. PubMed ID: 18535172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson's disease: a review.
    Leroi I; Collins D; Marsh L
    J Neurol Sci; 2006 Oct; 248(1-2):104-14. PubMed ID: 16806271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the treatment of cognitive impairment in Parkinson's disease.
    Goldman JG; Weintraub D
    Mov Disord; 2015 Sep; 30(11):1471-89. PubMed ID: 26297863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and dementia in Parkinson's disease: practical issues and management.
    Emre M; Ford PJ; Bilgiç B; Uç EY
    Mov Disord; 2014 Apr; 29(5):663-72. PubMed ID: 24757114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The practical management of cognitive impairment and psychosis in the older Parkinson's disease patient.
    Hindle JV
    J Neural Transm (Vienna); 2013 Apr; 120(4):649-53. PubMed ID: 23430276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive impairment and dementia in Parkinson's disease.
    Marder K
    Mov Disord; 2010; 25 Suppl 1():S110-6. PubMed ID: 20187235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Kulisevsky J
    Neurobiol Dis; 2012 Jun; 46(3):590-6. PubMed ID: 22484304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis.
    Wang HF; Yu JT; Tang SW; Jiang T; Tan CC; Meng XF; Wang C; Tan MS; Tan L
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):135-43. PubMed ID: 24828899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Memantine (akatinol) therapy of cognitive impairment in Parkinson's disease complicated by dementia].
    Litvinenko IV; Odinak MM; Mogil'naia VI; Perstenev SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(10):37-42. PubMed ID: 19008850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lewy body dementia and Parkinson's disease with dementia.
    Dodel R; Csoti I; Ebersbach G; Fuchs G; Hahne M; Kuhn W; Oechsner M; Jost W; Reichmann H; Schulz JB
    J Neurol; 2008 Sep; 255 Suppl 5():39-47. PubMed ID: 18787881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychiatric non-motor aspects of Parkinson's disease.
    Thanvi BR; Munshi SK; Vijaykumar N; Lo TC
    Postgrad Med J; 2003 Oct; 79(936):561-5. PubMed ID: 14612597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive impairment in Parkinson's disease and dementia with Lewy bodies.
    Aarsland D
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S144-8. PubMed ID: 26411499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing Cognitive Impairment in Parkinson's Disease.
    Bailey M; Goldman JG
    Semin Neurol; 2017 Apr; 37(2):167-175. PubMed ID: 28511257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neuropsychological impairment in Parkinson's disease without dementia].
    Marañón D; Amayra I; Uterga JM; Gómez-Esteban JC
    Psicothema; 2011 Nov; 23(4):732-7. PubMed ID: 22047866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions.
    Biundo R; Fiorenzato E; Antonini A
    Int Rev Neurobiol; 2017; 133():389-415. PubMed ID: 28802926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Parkinson's disease dementia : practical considerations.
    Rongve A; Aarsland D
    Drugs Aging; 2006; 23(10):807-22. PubMed ID: 17067184
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.